Targeting glycolytic pathway with 2-Deoxy-glucose enhances lapatinib sensitivity in HER2-amplified breast cancer

被引：0
|
作者：
Chen, Xiaosong [1 ]
Liu, Junjun [1 ]
Ward, Toby [2 ]
Liu, Xiaofei [2 ]
Mao, Yan [1 ]
Bockhorn, Jessica [2 ]
Shen, Kunwei [1 ]
Pegram, Mark [2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China
[2] Stanford Canc Inst, Stanford, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-713
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
713
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
    Lee-Hoeflich, Si Tuen
    Crocker, Lisa
    Yao, Evelyn
    Pham, Thinh
    Munroe, Xander
    Hoeflich, Klaus P.
    Sliwkowski, Mark X.
    Stern, Howard M.
    CANCER RESEARCH, 2008, 68 (14) : 5878 - 5887
  • [32] Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
    Luque-Cabal, Maria
    Garcia-Teijido, Paula
    Fernandez-Perez, Yolanda
    Sanchez-Lorenzo, Luisa
    Palacio-Vazquez, Isabel
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 21 - 30
  • [33] Prognostic and predictive implications of monosomy 17 in curable HER2-amplified breast cancer
    Page, David
    Wen, Yong H.
    Dure, Dana
    Hudis, Clifford
    Brogi, Edi
    McArthur, Heather
    CANCER RESEARCH, 2015, 75
  • [34] HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
    Gajria, Devika
    Chandarlapaty, Sarat
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 263 - 275
  • [35] Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
    Junttila, Teemu T.
    Parsons, Kathryn
    Olsson, Christine
    Lu, Yanmei
    Xin, Yan
    Theriault, Julie
    Crocker, Lisa
    Pabonan, Oliver
    Baginski, Tomasz
    Meng, Gloria
    Totpal, Klara
    Kelley, Robert F.
    Sliwkowski, Mark X.
    CANCER RESEARCH, 2010, 70 (11) : 4481 - 4489
  • [36] HER2-amplified gastric and colorectal cancers: Mechanistic insights into HER2 targeting approaches
    Leto, Simonetta Maria
    Sassi, Francesco
    Migliardi, Giorgia
    Zanella, Eugenia
    Catalano, Irene
    Bertotti, Andrea
    Trusolino, Livio
    CLINICAL CANCER RESEARCH, 2015, 21
  • [37] A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer
    Van Bockstal, M.
    Van Roy, N.
    Vergauwen, G.
    Lambein, K.
    Cocquyt, V.
    Libbrecht, L.
    Denys, H.
    Bracke, M.
    De Wever, O.
    BREAST, 2017, 32 : S48 - S48
  • [38] Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer
    Brown, Timothy J.
    Massa, Ryan C.
    JCO ONCOLOGY PRACTICE, 2022, 18 (08) : 555 - +
  • [39] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Avisek Majumder
    Manbir Sandhu
    Debarko Banerji
    Veronica Steri
    Adam Olshen
    Mark M. Moasser
    Scientific Reports, 11
  • [40] Transcriptome and genome evolution during HER2-amplified breast neoplasia
    Lu, Peipei
    Foley, Joseph
    Zhu, Chunfang
    McNamara, Katherine
    Sirinukunwattana, Korsuk
    Vennam, Sujay
    Varma, Sushama
    Fehri, Hamid
    Srivastava, Arunima
    Zhu, Shirley
    Rittscher, Jens
    Mallick, Parag
    Curtis, Christina
    West, Robert
    BREAST CANCER RESEARCH, 2021, 23 (01)
12345